A K Akobeng
Overview
Explore the profile of A K Akobeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1052
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malik S, Ahmed S, Wilson M, Shah N, Loganathan S, Naik S, et al.
J Crohns Colitis
. 2012 Mar;
6(3):337-44.
PMID: 22405171
Introduction: Adalimumab is used to treat children with Crohn's disease (CD), but the effects of adalimumab on growth in CD have not been studied. Aim: To study growth and disease...
2.
Ogden C, Akobeng A, Abbott J, Aggett P, Sood M, Thomas A
J Pediatr Gastroenterol Nutr
. 2011 Aug;
53(3):280-6.
PMID: 21865975
Objective: To validate IMPACT-III (UK), a health-related quality of life (HRQoL) instrument, in British children with inflammatory bowel disease (IBD). Patients And Methods: One hundred six children and parents were...
3.
Russell R, Wilson M, Loganathan S, Bourke B, Kiparissi F, Mahdi G, et al.
Aliment Pharmacol Ther
. 2011 Feb;
33(8):946-53.
PMID: 21342211
Background: Adalimumab is efficacious therapy for adults with Crohn's disease (CD). Aim: To summarise the United Kingdom and Republic of Ireland paediatric adalimumab experience. Methods: British Society of Paediatric Gastroenterology,...
4.
WILSON D, Thomas A, Croft N, Newby E, Akobeng A, Sawczenko A, et al.
J Pediatr Gastroenterol Nutr
. 2010 Jan;
50 Suppl 1:S14-34.
PMID: 20081542
Objective: To systematically review the evidence base for the medical (pharmaceutical and nutritional) treatment of paediatric inflammatory bowel disease. Methods: Key clinical questions were formulated regarding different treatment modalities used...
5.
6.
Akobeng A
Arch Dis Child
. 2008 May;
93(9):787-92.
PMID: 18456695
There is no known cure for Crohn's disease (CD), but a better understanding of the evidence base of both established treatments (such as enteral nutrition, corticosteroids, 5-aminosalicylates and immunosuppressive agents)...
7.
Akobeng A
Arch Dis Child
. 2008 May;
93(8):710-3.
PMID: 18456681
Although various measures can be used to describe the benefits and harms of treatments, not all of these clearly show the benefits or otherwise of treatments in a clinically useful...
8.
Zipitis C, Akobeng A
Arch Dis Child
. 2008 Mar;
93(6):512-7.
PMID: 18339654
Objectives: To assess whether vitamin D supplementation in infancy reduces the risk of type 1 diabetes in later life. Methods: This was a systematic review and meta-analysis using Medline, Embase,...
9.
Akobeng A, Thomas A
Aliment Pharmacol Ther
. 2008 Mar;
27(11):1044-52.
PMID: 18315587
Background: The threshold amount of gluten in 'gluten-free' products that can be tolerated by people with coeliac disease is unclear. Aim: To investigate the threshold amount of gluten and the...
10.
Akobeng A
Aliment Pharmacol Ther
. 2007 Oct;
27(1):11-8.
PMID: 17919275
Background: Crohn's disease is characterised by recurrent flare-ups alternating with periods of remission. A number of interventions are currently used in clinical practice to try and maintain remission in Crohn's...